177 related articles for article (PubMed ID: 22721615)
41. Lebectin, a Macrovipera lebetina venom-derived C-type lectin, inhibits angiogenesis both in vitro and in vivo.
Pilorget A; Conesa M; Sarray S; Michaud-Levesque J; Daoud S; Kim KS; Demeule M; Marvaldi J; El Ayeb M; Marrakchi N; Béliveau R; Luis J
J Cell Physiol; 2007 May; 211(2):307-15. PubMed ID: 17323383
[TBL] [Abstract][Full Text] [Related]
42. Antiangiogenic activity of beta-eudesmol in vitro and in vivo.
Tsuneki H; Ma EL; Kobayashi S; Sekizaki N; Maekawa K; Sasaoka T; Wang MW; Kimura I
Eur J Pharmacol; 2005 Apr; 512(2-3):105-15. PubMed ID: 15840394
[TBL] [Abstract][Full Text] [Related]
43. Paeonol exerts anti-angiogenic and anti-metastatic activities through downmodulation of Akt activation and inactivation of matrix metalloproteinases.
Kim SA; Lee HJ; Ahn KS; Lee HJ; Lee EO; Ahn KS; Choi SH; Jung SJ; Kim JY; Baek N; Kim SH
Biol Pharm Bull; 2009 Jul; 32(7):1142-7. PubMed ID: 19571375
[TBL] [Abstract][Full Text] [Related]
44. Synthesis and evaluation of nicotinamide derivative as anti-angiogenic agents.
Choi HE; Choi JH; Lee JY; Kim JH; Kim JH; Lee JK; Kim GI; Park Y; Chi YH; Paik SH; Lee JH; Lee KT
Bioorg Med Chem Lett; 2013 Apr; 23(7):2083-8. PubMed ID: 23453071
[TBL] [Abstract][Full Text] [Related]
45. Anti-angiogenic activity of salvicine.
Zhang Y; Wang L; Chen Y; Qing C
Pharm Biol; 2013 Aug; 51(8):1061-5. PubMed ID: 23750780
[TBL] [Abstract][Full Text] [Related]
46. Structure-activity relationships of the human prothrombin kringle-2 peptide derivative NSA9: anti-proliferative activity and cellular internalization.
Hwang HS; Kim DW; Kim SS
Biochem J; 2006 Apr; 395(1):165-72. PubMed ID: 16390327
[TBL] [Abstract][Full Text] [Related]
47. In vitro and in vivo study of hydralazine, a potential anti-angiogenic agent.
Zhang Q; Lin Z; Yin X; Tang L; Luo H; Li H; Zhang Y; Luo W
Eur J Pharmacol; 2016 May; 779():138-46. PubMed ID: 26968484
[TBL] [Abstract][Full Text] [Related]
48. Toluquinol, a marine fungus metabolite, is a new angiosuppresor that interferes with the Akt pathway.
García-Caballero M; Marí-Beffa M; Cañedo L; Medina MÁ; Quesada AR
Biochem Pharmacol; 2013 Jun; 85(12):1727-40. PubMed ID: 23603293
[TBL] [Abstract][Full Text] [Related]
49. Interaction between 8-hydroxyquinoline ruthenium(II) complexes and basic fibroblast growth factors (bFGF): inhibiting angiogenesis and tumor growth through ERK and AKT signaling pathways.
Yang L; Zhang J; Wang C; Qin X; Yu Q; Zhou Y; Liu J
Metallomics; 2014 Mar; 6(3):518-31. PubMed ID: 24336978
[TBL] [Abstract][Full Text] [Related]
50. Synthesis and biological evaluation of scopoletin derivatives.
Cai X; Yang J; Zhou J; Lu W; Hu C; Gu Z; Huo J; Wang X; Cao P
Bioorg Med Chem; 2013 Jan; 21(1):84-92. PubMed ID: 23218780
[TBL] [Abstract][Full Text] [Related]
51. NBBA, a synthetic small molecule, inhibits TNF-alpha-induced angiogenesis by suppressing the NF-kappaB signaling pathway.
Kim NH; Jung HJ; Shibasaki F; Kwon HJ
Biochem Biophys Res Commun; 2010 Jan; 391(3):1500-5. PubMed ID: 20035721
[TBL] [Abstract][Full Text] [Related]
52. Anti inflammatory and anti angiogenic effect of black raspberry extract on human esophageal and intestinal microvascular endothelial cells.
Medda R; Lyros O; Schmidt JL; Jovanovic N; Nie L; Link BJ; Otterson MF; Stoner GD; Shaker R; Rafiee P
Microvasc Res; 2015 Jan; 97():167-80. PubMed ID: 25446010
[TBL] [Abstract][Full Text] [Related]
53. Effect of resveratrol on angiogenesis and platelet/fibrin-accelerated tumor growth in the chick chorioallantoic membrane model.
Mousa SS; Mousa SS; Mousa SA
Nutr Cancer; 2005; 52(1):59-65. PubMed ID: 16091005
[TBL] [Abstract][Full Text] [Related]
54. Antiangiogenic Effect of Flavonoids and Chalcones: An Update.
Mirossay L; Varinská L; Mojžiš J
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29271940
[TBL] [Abstract][Full Text] [Related]
55. Anti-angiogenic activity of a new andrographolide derivative in zebrafish and HUVECs.
Li J; Peng Y; Li S; Sun Y; Chan JY; Cui G; Wang D; Zhou GC; Lee SM
Eur J Pharmacol; 2016 Oct; 789():344-353. PubMed ID: 27471159
[TBL] [Abstract][Full Text] [Related]
56. Potent pleiotropic anti-angiogenic effects of TM601, a synthetic chlorotoxin peptide.
Jacoby DB; Dyskin E; Yalcin M; Kesavan K; Dahlberg W; Ratliff J; Johnson EW; Mousa SA
Anticancer Res; 2010 Jan; 30(1):39-46. PubMed ID: 20150615
[TBL] [Abstract][Full Text] [Related]
57. Inhibition of angiogenesis in endothelial cells by Human Lysyl oxidase propeptide.
Nareshkumar RN; Sulochana KN; Coral K
Sci Rep; 2018 Jul; 8(1):10426. PubMed ID: 29993014
[TBL] [Abstract][Full Text] [Related]
58. A novel bisindole-PBD conjugate inhibits angiogenesis by regulating STAT3 and VEGF in breast cancer cells.
Sarma P; Ramaiah MJ; Pal D; Bhadra U; Pal Bhadra M
Life Sci; 2016 Apr; 151():264-276. PubMed ID: 26979778
[TBL] [Abstract][Full Text] [Related]
59. Evodiamine inhibits in vitro angiogenesis: Implication for antitumorgenicity.
Shyu KG; Lin S; Lee CC; Chen E; Lin LC; Wang BW; Tsai SC
Life Sci; 2006 Apr; 78(19):2234-43. PubMed ID: 16280136
[TBL] [Abstract][Full Text] [Related]
60. Pharmacologic characterization of a kinetic in vitro human co-culture angiogenesis model using clinically relevant compounds.
Wolfe A; O'Clair B; Groppi VE; McEwen DP
J Biomol Screen; 2013 Dec; 18(10):1234-45. PubMed ID: 24019254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
